Published in Gene Therapy Weekly, September 14th, 2006
Study 1: According to recent research from England published in the journal Science, a regulatory single nucleotide polymorphism (SNP) causes a human genetic disease by creating a new transcriptional promoter.
"We describe a pathogenetic mechanism underlying a variant form of the inherited blood disorder thalassemia," wrote M. Degobbi and colleagues, John Radcliffe Hospital.
"Association studies of affected individuals from Melanesia localized the disease trait to the telomeric region of human chromosome 16, which includes...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2006-09-14)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.